Overview

Uncontrolled growth and abnormal cellular behaviour are traits of cancer cells and immune cells that contribute to autoimmune and inflammatory disorders. CV6 Therapeutics is developing innovative new medicines to block the growth and control the behaviour of these abnormal cells. By doing this, we aim to develop new treatments that will make a real difference in the lives of patients and their families. We are advancing a growing pipeline of investigational therapeutics that will enhance the effectiveness of some of the most commonly used standard-of-care therapies for the treatment of cancer and inflammatory conditions.